abatacept vs meloxicam
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of abatacept and meloxicam. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Orencia is a medicine that helps to reduce inflammation. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID). It helps to reduce pain and swelling.
Orencia treats rheumatoid arthritis in adults. It also treats polyarticular juvenile idiopathic arthritis in patients 2 years and older. Orencia can also treat active psoriatic arthritis in patients 2 years and older. Finally, it can prevent acute graft versus host disease after a stem cell transplant.
Meloxicam treats the symptoms of osteoarthritis and rheumatoid arthritis. It can also treat juvenile rheumatoid arthritis in children who weigh at least 132 pounds (60 kg). This medicine helps to relieve pain, swelling, and stiffness in your joints.
Orencia works by blocking the activity of certain immune cells called T cells. These T cells can cause inflammation and damage to your joints and other tissues. By blocking T cell activity, Orencia can help reduce inflammation and relieve your symptoms.
Meloxicam works by reducing substances in the body that cause pain and inflammation. It blocks the production of prostaglandins. Prostaglandins contribute to inflammation and pain.
- • Headache
- • Upper respiratory tract infection (like a cold)
- • Runny nose
- • Nausea
- • Diarrhea
- • Upper respiratory infection
- • Upset stomach
- • Flu-like symptoms
- Rheumatoid Arthritis 23,596
- Pain 21,295
- Arthralgia 20,151
- Joint Swelling 19,709
- Fatigue 14,200
- Pain 4,670
- Fatigue 4,578
- Arthralgia 4,222
- Nausea 3,807
- Headache 3,323
Using Orencia with a TNF antagonist or other biologic medicines can raise your risk of serious infections. Tell your doctor if you have any signs of infection, such as fever, cough, or sore throat. Orencia can also cause allergic reactions, including anaphylaxis. Get medical help right away if you have trouble breathing, swelling, or hives.
Meloxicam may increase your risk of serious heart problems, including heart attack and stroke, which can be fatal. This risk may occur early in treatment and may increase with longer use. You should not take meloxicam if you are having heart bypass surgery. Meloxicam can also increase your risk of serious stomach and intestinal problems, including bleeding, ulcers, and holes, which can be fatal. These problems can occur without warning. The elderly and those with a history of ulcers are at greater risk.
There is not enough information about Orencia use in pregnant women to know if it is safe. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Using meloxicam between 20 and 30 weeks of pregnancy may cause kidney problems in the baby, leading to low amniotic fluid. Avoid using meloxicam after 30 weeks of pregnancy because it can cause heart problems in the baby. Talk to your doctor if you are pregnant or plan to become pregnant.
Also Compare, Nearby Drugs
Compare meloxicam with
How to Read This abatacept vs meloxicam Comparison
abatacept is classified in the T-Cell Co-Stimulation Modulator drug class, while meloxicam sits within the Nonsteroidal Anti-Inflammatory Drug (NSAID) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abatacept has 98,951 submissions while meloxicam has 20,600. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for abatacept or meloxicam.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.